Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticlePediatric Neuroimaging
Open Access

Cavum Septum Pellucidum in the General Pediatric Population and Its Relation to Surrounding Brain Structure Volumes, Cognitive Function, and Emotional or Behavioral Problems

M.H.G. Dremmen, R.H. Bouhuis, L.M.E. Blanken, R.L. Muetzel, M.W. Vernooij, H.E. Marroun, V.W.V. Jaddoe, F.C. Verhulst, H. Tiemeier and T. White
American Journal of Neuroradiology January 2019, DOI: https://doi.org/10.3174/ajnr.A5939
M.H.G. Dremmen
aFrom the Departments of Radiology (M.H.G.D., R.H.B., M.W.V., T.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M.H.G. Dremmen
R.H. Bouhuis
aFrom the Departments of Radiology (M.H.G.D., R.H.B., M.W.V., T.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R.H. Bouhuis
L.M.E. Blanken
dDepartment of Child and Adolescent Psychiatry (L.M.E.B., R.L.M., H.E.M., F.C.V., H.T., T.W.)
eGeneration R Study Group (L.M.E.B., R.L.M., H.E.M.), Erasmus Medical Center-Sophia, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L.M.E. Blanken
R.L. Muetzel
bEpidemiology (R.L.M., M.W.V., V.W.V.J.)
dDepartment of Child and Adolescent Psychiatry (L.M.E.B., R.L.M., H.E.M., F.C.V., H.T., T.W.)
eGeneration R Study Group (L.M.E.B., R.L.M., H.E.M.), Erasmus Medical Center-Sophia, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R.L. Muetzel
M.W. Vernooij
aFrom the Departments of Radiology (M.H.G.D., R.H.B., M.W.V., T.W.)
bEpidemiology (R.L.M., M.W.V., V.W.V.J.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M.W. Vernooij
H.E. Marroun
dDepartment of Child and Adolescent Psychiatry (L.M.E.B., R.L.M., H.E.M., F.C.V., H.T., T.W.)
eGeneration R Study Group (L.M.E.B., R.L.M., H.E.M.), Erasmus Medical Center-Sophia, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for H.E. Marroun
V.W.V. Jaddoe
bEpidemiology (R.L.M., M.W.V., V.W.V.J.)
cPediatrics (V.W.V.J.), Erasmus Medical Center, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for V.W.V. Jaddoe
F.C. Verhulst
dDepartment of Child and Adolescent Psychiatry (L.M.E.B., R.L.M., H.E.M., F.C.V., H.T., T.W.)
fDepartment of Clinical Medicine (F.C.V.), University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F.C. Verhulst
H. Tiemeier
dDepartment of Child and Adolescent Psychiatry (L.M.E.B., R.L.M., H.E.M., F.C.V., H.T., T.W.)
gHarvard School of Public Health (H.T.), Boston, Massachusetts.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for H. Tiemeier
T. White
aFrom the Departments of Radiology (M.H.G.D., R.H.B., M.W.V., T.W.)
dDepartment of Child and Adolescent Psychiatry (L.M.E.B., R.L.M., H.E.M., F.C.V., H.T., T.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for T. White
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

BACKGROUND AND PURPOSE: The cavum septum pellucidum, a cavity filled with CSF, is localized between the 2 lateral ventricles of the brain. The cavum is present in all neonates, but it typically closes within 5 months after birth. In some cases, this closure does not occur and a persistent or enlarged cavum septum pellucidum has been linked, in some studies, to psychiatric disorders. However, the clinical relevance in the general population is unknown. In this study, we examined the relationship between the cavum septum pellucidum and volumes of brain structures, cognitive function, and emotional and behavioral problems in children.

MATERIALS AND METHODS: This study was embedded in the Generation R Study, a prospective cohort in Rotterdam, the Netherlands. MR imaging studies of 1070 children, 6–10 years of age, were systematically evaluated for the presence and length of a persistent cavum septum pellucidum. An enlarged cavum septum pellucidum was defined as a cavum length of ≥6 mm. Groups without, with persistent, and with enlarged cavum septi pellucidi were compared for brain structure volumes, nonverbal intelligence, and emotional and behavioral problems.

RESULTS: The prevalence of cavum septi pellucidi in our sample was 4.6%. Children with an enlarged cavum septum pellucidum had a larger corpus callosum, greater thalamic and total white matter–to–total brain volume ratio, and smaller lateral ventricle volumes. We did not find a relationship between cavum septi pellucidi and cognitive function or emotional and behavioral problems.

CONCLUSIONS: The cavum septum pellucidum is a normal structural brain variation without clinical implications in this population-based sample of school-aged children.

ABBREVIATIONS:

CBCL
Child Behavior Checklist
CSP
cavum septum pellucidum
IQ
intelligence quotient
M
marginal mean
ρs
Spearman partial correlation
SE
standard error

The septum pellucidum is a thin plate consisting of 2 fused laminae or septa located between the lateral ventricles of the brain. At birth, these 2 septa are separated and form the lateral walls of a cavity filled with CSF, the cavum septum pellucidum (CSP). The 2 septa of the cavum typically fuse into a single septum pellucidum within 5 months after birth, likely due to growth of the surrounding brain structures.1⇓–3 However, in some cases, the septa do not fuse and form the persistent cavum. A persistent CSP with a cavum length of <5 mm is common in a large proportion of healthy subjects, with prevalence rates of up to 30% in the adult population,1,4 and is therefore considered a normal variant. In general, the size of a normal-variant septum is estimated at approximately 1–4 mm.1,5 There is no clear cutoff value to define enlargement of the CSP, but many previous studies used a common cutoff of ≥6 mm.2,3,5⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓–16

In patients with schizophrenia and an enlarged CSP, smaller amygdala volumes and smaller left posterior parahippocampal gyrus volumes compared with patients without CSP were found.12 Other studies did not find a relation to global or specific brain structure volumes.7,9,13,17 However, because the postnatal closure of the CSP is presumed to be dependent on growing brain structures,2,3 we would expect the brain regions in direct or close contact with the septum pellucidum to be smaller in subjects with enlarged CSPs.

Because an enlarged CSP is considered a neurodevelopmental anomaly, it has been postulated as a potential marker for psychiatric disorders that have neurodevelopmental origins. Indeed, an enlarged CSP has been evaluated in a broad range of psychiatric adult populations, typically by measuring the anterior-to-posterior CSP length on MR imaging studies, but with mixed results. Some studies have shown significantly higher rates of enlarged CSPs in adult patients with schizophrenia,5,9,18 schizophrenia spectrum disorder,18 bipolar disorder,11 and disruptive behavior disorder19 and opiate-dependent subjects.16 However, other studies did not find higher rates of enlarged CSPs in schizophrenia,2,6,10,12,20 bipolar disorder,21 and other psychiatric disorders, including attention deficit/hyperactivity disorder,22 borderline personality disorder,13 depression,13 or obsessive-compulsive disorder.14

The relationship between CSP and cognition is even less clear. Nopoulos et al23 found a negative correlation between cavum length and the intelligence quotient (IQ) in patients with schizophrenia and an enlarged CSP; however, they did not show this relationship between an enlarged CSP and cognition in the control group. On the other hand, another study has found that a larger proportion of subjects evaluated for mental retardation also had an enlarged CSP.24 In addition, an enlarged CSP has been found in children with syndromes that include cognitive impairments such as fetal alcohol syndrome25 or Apert syndrome.26 These studies may suggest that a relationship exists between an enlarged CSP and cognitive function that extends to the general population.

The heterogeneity in different cutoffs used to define the presence of an enlarged CSP could contribute to some of the mixed findings. The presence of an enlarged CSP, according to the ≥6-mm cutoff varied from 0% to 19.5% in patients and from 0% to 14.7% in controls.2,3,6⇓⇓⇓⇓⇓⇓⇓⇓⇓–16 Because control groups for clinical studies do not always reflect the general population, the prevalence of an enlarged CSP in the general pediatric population is unknown. Thus, the goal of this study was to determine the prevalence of a CSP in the general pediatric population and to examine the relationship between the size of a CSP and brain structure volumes, nonverbal intelligence (as a proxy for cognitive function), and emotional or behavioral problems in children.

Given the previously reported link between an enlarged CSP and behavioral or emotional disorders,11,15,19 we hypothesized that a relationship between the size of a CSP and behavioral problems and cognitive performance would be present in a population-based sample of children.

Materials and Methods

Participants

The current study was embedded in the longitudinal population-based Generation R Study. An overview of the Generation R Study design is published elsewhere.27,28 Briefly, the Generation R Study is a prospective birth cohort study that started in Rotterdam between 2002 and 2006. After informed consent was obtained, a total of 9778 pregnant women were included. Information on the demographic characteristics included educational levels of the mother. Multiple measurements were collected during pregnancy (eg, maternal alcohol use and smoking behavior).29 A neuroimaging substudy of children 6–9 years of age was initiated in 2009 and involved 1070 children.28 Exclusion criteria were general contraindications for MR imaging examination (ie, pacemaker, ferrous metal implants), severe motor or sensory disorders (deafness or blindness), neurologic disorders (ie, seizures or tuberous sclerosis), moderate-to-severe head injuries with loss of consciousness, and claustrophobia. Informed consent was obtained from the parents before participation. The study was approved by the Medical Ethics Committee at the Erasmus Medical Center-Sophia, Rotterdam.28

MR Imaging Acquisition

Children were familiarized with the MR imaging scanners using a mock scanning procedure.28 MR images were acquired on a 3T scanner (Discovery MR750; GE Healthcare, Milwaukee, Wisconsin) using an 8-channel head coil for signal reception. Following a 3-plane localizing and coil-intensity calibration scan, a high-resolution T1-weighted inversion recovery fast-spoiled gradient-recalled sequence was obtained with the following parameters: TR = 10.3 ms, TE = 4.2 ms, TI = 350 ms, NEX = 1, flip angle = 16°, readout bandwidth = 20.8 kHz, matrix = 256 × 256. The total scan time for the T1 was 5 minutes 40 seconds.28 The MR images underwent a 6-parameter affine transformation into a study-specific template at 1 × 1 × 1 mm isotropic resolution.30

CSP Assessment

The CSP was assessed in a standardized manner by a single trained neuroradiologist, blinded to subject information. Anatomic boundaries for the CSP were as follows: the genu of the corpus callosum defined the anterior boundary, the body of the corpus callosum defined the superior boundary, the rostrum of the corpus callosum and the anterior commissure defined the inferior boundary, and the anterior limb and pillars of the fornix defined the posterior boundary. On-line Fig 1 illustrates the anterior and posterior boundaries of the CSP in the sagittal plane. Similar to other studies,5⇓⇓⇓–9,12,13,15,19,20,22,23 the anterior-to-posterior length of the CSP was measured by counting the number of coronal 1-mm slices on which a cavum was visible. A cavum was labeled as enlarged when its length was ≥6 slices (ie, ≥6 mm).2,3,6⇓⇓⇓⇓⇓⇓⇓⇓⇓–16 Absence of a CSP was labeled “no CSP.” A cavum of <6 mm in length was categorized as a normal-variant CSP. Figure 1 illustrates the presence of an enlarged CSP. Intrarater reliability was based on 50 repeat ratings and was found to be high (test-retest reliability, Cronbach α = 0.96). Scans that were of insufficient quality to determine the existence or length of a CSP were excluded from the analyses (12.5%, n = 134). The insufficient scan quality was mainly due to movement artifacts, which are a well-known problem when performing MR imaging studies in unsedated children at a young age.

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

MR imaging of the cavum septum pellucidum. Coronal T1-weighted MR image (A) and axial T1-weighted MR image (B) show no CSP. C, Coronal T1-weighted MR image (C) and axial T1-weighted MR image (D) demonstrate an enlarged CSP.

Global and Regional Brain Structures

Volumes of global and regional brain structures were measured using FreeSurfer image analysis, Suite 5.1 (http://surfer.nmr.mgh.harvard.edu/). The technical details of these procedures have been described elsewhere.31,32 Briefly, this process included intensity normalization, the removal of nonbrain tissue, automated Talairach transformation into standard space, and segmentation of the cortical and subcortical white and gray matter volumetric structures. The volumes of brain regions in close vicinity to the CSP were selected for analysis. These regions included the corpus callosum, lateral ventricles, thalamus, hippocampus, amygdala, and the caudate nucleus. Volumes of global brain measures were also examined, including total brain, total gray matter, and total white matter volumes.

Emotional and Behavioral Problems

Emotional and behavioral problems were measured using the sum scores of the 99 items of the Child Behavior Checklist (CBCL).33 This questionnaire, completed by the parents when the children were approximately 6 years of age, includes behavioral, emotional, and social problems in school-aged children. The items were calculated for several syndrome scales: emotionally reactive, anxious/depressed, somatic complaints, withdrawn, attention problems, and aggressive behavior. Broadband scores of internalizing symptoms and externalizing symptoms were used.

Nonverbal Intelligence

The Generation R cohort includes children from different ethnic minorities with differences in Dutch language abilities. Therefore, nonverbal intelligence was measured using 2 subtests of the Snijders-Oomen Nonverbal Intelligence Test 2.5–7-Revised.34 Due to time constraints, we selected 2 subtests: Mosaics and categories for testing spatial insight and abstract reasoning abilities, respectively. Because the correlation between the sum of these 2 subtests and the full SON-R IQ battery is very high (r = 0.86), these subdomain scores can be used as nonverbal IQ scores.35 Raw subtest scores were transformed according to population- and age-specific norms with a mean value of 100 ± 15.36 Handedness was determined using the Edinburgh Handedness Inventory.29

Statistical Analyses

Demographic differences between the no/normal-variant CSP (control group) and the enlarged CSP group were analyzed using a χ2 test for categoric variables (sex, ethnicity, handedness, maternal education, maternal alcohol use during pregnancy, maternal smoking behavior during pregnancy) and independent t tests for continuous variables (age). Differences in brain structure volumes, nonverbal intelligence, and emotional and behavioral problems between the controls and the enlarged CSP group were tested using ANCOVAs. Covariates were added to the model if they resulted in a >5% change in the effect estimate, including the child's age, sex, ethnicity, and maternal education. The analyses of regional brain structure volumes were also adjusted for total problem score and total brain volume. Because the control group did include a small CSP (0–5 mm) and the biologic relevance of a normal-sized CSP is not clear, 2 additional sensitivity analyses were performed for brain structure volumes, nonverbal intelligence, and emotional and behavior problems. First, sensitivity analyses were performed comparing the 2 extreme categories (0 versus ≥6 mm), and second, an analysis was performed using a classification into 3 groups (0 versus 1–5 versus ≥6 mm). For certain analyses of brain structure volumes and emotional or behavioral scores, the length of the CSP was used as a continuous variable.

All analyses were performed using the Statistical Package for the Social Sciences, Version 21.0 (SPSS; IBM, Armonk, New York). In addition, a nonparametric analysis with CSP length as a continuous variable was performed using Statistical Analysis Software, Version 9.3 (SAS Institute, Cary, North Carolina). To correct for multiple testing, we calculated the effective number of tests on the basis of the covariance structure among the different outcomes.37 We found the number of effective tests to be 5; thus, the corrected threshold for significance was P < .01. Data were missing on internalizing symptoms (10.5% missing data), externalizing symptoms (10.0%), nonverbal IQ (8.8%), and the covariates, maternal education (9.5%) and the CBCL sum score (9.5%). Missing values were estimated using a multiple imputation method with 5 imputations and 10 iterations. Finally, an additional nonresponse analysis was performed comparing the baseline characteristics of the study participants with the group of children excluded due to insufficient scan quality.

Results

Sample Characteristics

Sample characteristics are presented in Table 1. Children in the control group and the enlarged CSP group did not differ in age at scanning [t(934) = 0.26, P = .79)], sex [χ2(1) = 0.03, P = .86], ethnicity [χ2(2) = 2.68, P = .26], handedness [χ2(1) = 0.001, P = .98], maternal education [χ2(2) = 0.93, P = .63], maternal alcohol use during pregnancy [χ2(3) = 1.53, P = .68], and maternal smoking behavior during pregnancy [χ2(2) = 0.23, P = .89].

View this table:
  • View inline
  • View popup
Table 1:

Sample characteristics

CSP

Figure 2 shows the distribution of the anterior-to-posterior cavum lengths in the entire sample. The prevalence of a CSP in the study population was 64.9%, categorized into normal-variant CSP (60.3% of total study population) and enlarged CSP (4.6% of total study population). The mean cavum length in the control group was 2.67 mm; lengths ranged from 1 to 5 mm. The mean cavum length in the enlarged CSP group was 12.56 mm; lengths in this group ranged from 6 to 37 mm. A histogram of CSP lengths in the enlarged CSP group is shown in On-line Fig 2.

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

Distribution of no CSP, normal-variant CSP, and enlarged CSP for the whole sample (n = 936).

Global Brain Structures

Table 2 shows the differences in global structure volumes between the controls and the enlarged CSP group. Children in the enlarged CSP group had larger total brain volumes [F(1,93) = 3.93, P = 0.05, partial η2 = 0.004] and larger total white matter/total brain ratio volumes [F(1,93) = 6.81, P = .009, partial η2 = 0.007] compared with the children in the control group, adjusting for the covariates. After correcting for multiple testing, only the difference in white matter/total brain ratio volume remained. Comparing the children in the controls (n = 893) with the those in the enlarged CSP group (n = 43) or comparison of the 3 groups (0 versus 1–5 versus ≥6 mm) showed similar results. CSP length was positively correlated with total brain volume (Spearman partial correlation, ρs = 0.19, P < .001) and white matter/total brain ratio volume (Spearman partial correlation, ρs = 0.13, P < .001).

View this table:
  • View inline
  • View popup
Table 2:

ANCOVA for global brain structuresa

Regional Brain Structures

Table 3 shows the difference in volumes of specific structures between the controls and the enlarged CSP group. Children in the enlarged CSP group had larger corpus callosum volumes [F(1,93) = 6.79, P = .009, partial η2 = 0.007], larger thalamus volumes [F(1,93) = 11.21, P = .001, partial η2 = 0.012], and smaller amygdala volumes [F(1,93) = 4.48, P = 0.04, partial η2 = 0.005] compared with the children in the control group, after controlling for covariates. After we corrected for multiple testing, only differences in the corpus callosum and thalamus volumes remained. On-line Table 1 presents the results of the comparison of children in the no-CSP group (n = 329) with the those in the enlarged CSP group (≥6 mm). Additionally, children with an enlarged CSP had smaller lateral ventricle volumes compared with children with complete absence of a cavum [F(1,36) = 8.16, P = .005, partial η2 = 0.022]. On-line Table 2 presents the results of the comparison of the 3 groups (0 versus 1–5 versus ≥6 mm). In this analysis, the difference in amygdala volume disappeared, and the 3 groups were found to differ in caudate nucleus volume [F(2,93) = 5.33, P = .005, partial η2 = 0.011]. CSP length was positively correlated with the volume of the corpus callosum (Spearman partial correlation, ρs = 0.12, P < .001), thalamus (Spearman partial correlation, ρs = 0.08, P = .02), and caudate nucleus (Spearman partial correlation, ρs = −.10, P = .002) and was negatively correlated with lateral ventricle volumes (Spearman partial correlation, ρs = −.20, P < .001).

View this table:
  • View inline
  • View popup
Table 3:

ANCOVA for regional brain structures (control vs enlarged CSP)a

Nonverbal Intelligence

Children in the no/normal-sized CSP and the enlarged CSP groups did not differ in nonverbal IQ scores [F(1,93) = 0.05, P = 0.82, partial η2 = 0.000]. Estimated marginal means (M) for nonverbal IQ were M = 101.63, standard error (SE) = 0.46 versus M = 101.13, SE = 2.08. The results of comparing the children in the no-CSP group (n = 329) with the enlarged CSP group (n = 43) were also not significant. Comparing 3 groups (0 versus 1–5 versus ≥6 mm) did show a difference in nonverbal IQ scores [F(1,93) = 3.37, P = 0.04, partial η2 = 0.007]. Estimated marginal means for the 3 groups were M = 100.08, SE = 0.75 versus M = 102.53, SE = 0.57 versus M = 101.14, SE = 2.07; however, this finding did not survive correction for multiple testing. A nonparametric test with CSP length as a continuous variable did not show a correlation between CSP length and nonverbal IQ scores.

Emotional or Behavioral Problems

Children in the control group and the enlarged CSP group did not differ in emotional [F(1,93) = 2.35, P = 0.13, partial η2 = 0.003] or behavioral [F(1,93) = 0.35, P = 0.55, partial η2 = 0.000] problem scores. Estimated marginal means for emotional scores were M = 2.48, SE = 0.04 versus M = 2.18, SE = 0.19. Estimated marginal means for behavioral scores were M = 2.80, SE = 0.04 versus M = 2.93, SE = 0.20. Mean scores are reported as square-root-transformed scores. Comparing the children in the no-CSP group (n = 329) with those in the enlarged CSP group (n = 43) or comparing 3 groups (0 mm 1–5 versus ≥6 mm) did not change the results. A Spearman correlation coefficient test with CSP length as a continuous variable also did not show a correlation between CSP length and emotional or behavioral scores.

Participant versus Excluded Analysis

Of all 1070 scans, 134 scans (12.5%) were of insufficient quality and were excluded from the analyses. Children whose scans were excluded did not differ from the current study sample (n = 936) in age at the time of scanning [t(1068) = −0.81, P = .42], sex [χ2(1) = 3.18, P = .07], ethnicity [χ2(2) = 3.85, P = .15], handedness [χ2(1) = 0.43, P = .51], nonverbal IQ [t(980) = −0.59, P = .56], maternal education [χ2(2) = 3.83, P = .15], maternal alcohol use during pregnancy [χ2(3) = 1.12, P = .77], and maternal smoking behavior during pregnancy [χ2(2) = 5.64, P = .06]. However, children excluded from the analyses had higher CBCL sum scores than the included children [t(970) = 2.53, P = .01].

Discussion

To further understand the brain structural correlates associated with an enlarged CSP, we evaluated the relationship between the CSP and the volume of global and regional brain structures. Children with enlarged CSPs were found to have larger total white matter/total brain volume ratios and corpus callosum and thalamus volumes. Similar to studies in patients with schizophrenia spectrum disorder,12 amygdala volumes were smaller in subjects with enlarged CSPs. However, this result did not remain significant after correction for multiple testing. In addition, children with enlarged CSPs had smaller lateral ventricle volumes compared with children with a total absence of a cavum. CSP length was positively correlated with total brain volume; white matter/total brain ratio; and corpus callosum, thalamus, and caudate nucleus volumes. CSP length was negatively correlated with lateral ventricle volumes.

It has been postulated that the postnatal closure of the CSP is a result of growth of surrounding brain structures, exerting pressure on the 2 leaflets of the septum pellucidum and thereby facilitating fusion.2,3 Brain development in this early postnatal period has not been extensively studied, but a recent study on infant brain development in the first 3 months after birth38 presents growth rates for several ROIs of the current study. The lateral ventricles were found to grow at the highest rate, increasing around 78% in the first 90 days after birth. As hypothesized, the rapid growth of the lateral ventricles in these first months after birth could induce closure of the cavum by exerting lateral pressure on both sides of the septal leaves. We speculated that smaller growth rates in this period could cause failure of CSP closure. If these early growth rates are decisive for structure volumes at a later age, our results support this hypothesis because the lateral ventricles were smaller in children with the presence of a CSP compared with those with total absence of a cavum. Previous studies have reported an association between an enlarged CSP and syndromes including cognitive impairment such as fetal alcohol syndrome and Apert syndrome.25,26

Mechanical factors that potentially play a role in the closure of the CSP in the general pediatric population could also extend to these clinical conditions. In these syndromes, there is an obvious change in brain volume and/or head size, which could cause major changes in the exerting pressure on the septal leaves, leading to a failure of CSP closure. The enlarged CSP would rather be a consequence of the anatomic and structural abnormalities in these syndromes than a marker of cognitive function itself. In addition, the larger total amount of white matter (larger total white matter/total brain volumes ratios) in the enlarged CSP group could also contribute to a change in mechanical factors that cause the lateral ventricles to grow less rapidly in the early postnatal period. This, in turn, could modify the exerting lateral pressure on both sides of the septal leaves and alter the possible closure mechanisms of the septal leaves.

In addition, other regional brain structures were also found to be larger in children with a persistent CSP. For example, the corpus callosum is a structure that directly surrounds the CSP but was found to be larger in children with an enlarged CSP. We speculated that the exertion of lateral pressure, like the pressure of growing lateral ventricles, is more effective in facilitating the postnatal fusing process of the septum leaves if the corpus callosum is smaller. Thus, under the rubric of a mechanical closure hypothesis of the CSP, larger brain structures would require greater distributed pressure along the structure to close the septum. However, because we do not have MR imaging data available during the early postnatal period, it is not possible to draw conclusions concerning the timing and longitudinal relationship with neighboring structures related to the postnatal closure of the CSP. It is likely that multiple-yet-unknown factors play a role in this process.

Furthermore, it would be interesting to search for genetic factors that play a role in the closure of the CSP. Because the Generation R Study is currently starting to prospectively scan the parents of a subgroup of children scanned in this study, assessment of the presence and size of a CSP in the parents could be of great value to demonstrate the influence of genetics. This may well be a focus of further studies.

The prevalence of an enlarged CSP in our population-based sample of school-aged children is 4.6%. This falls within the range described in prior literature in adult populations.2,3,5⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓–16 While earlier research tended to focus on psychiatric populations, the prevalence in healthy control groups in these studies varied substantially from 0% to 14.7%. Because many of these studies had small sample sizes and control groups are not always reflective of recruitment from the general population, we believe that our study provides more accurate rates of enlarged CSPs in the general pediatric population. However, we are unaware of studies assessing changes with time in the size or presence of the CSP; thus, longitudinal studies are necessary to address this question.

An enlarged CSP is considered a potential marker for neurodevelopmental abnormalities. However, in contrast to earlier studies,11,15,19 we did not find a relationship between an enlarged CSP and nonverbal intelligence. We also did not find a relationship between emotional or behavioral problems and an enlarged CSP. While we found no evidence for behavioral correlates of an enlarged CSP in this population-based sample of school-aged children, some neuropsychiatric disorders that show a relationship with an enlarged CSP have a typical age of onset in late adolescence and early adulthood. For example, schizophrenia spectrum disorders and bipolar disorders generally present with the first symptoms between 17 and 25 years of age.7,21 Thus, it is possible that the relationship between an enlarged CSP and psychopathology will emerge later, parallel to the emergence of psychiatric symptoms. The small, nonsignificant, volumetric differences of certain brain structures found in this study could theoretically indicate some structural changes in brain regions that might form the basis for these diseases.

There are some limitations in the study protocol. Only 1 rater evaluated the MR imaging studies and assessed the presence and size of the CSP. However, the rater was specifically trained to evaluate the CSP and performed all the measurements in a standardized manner. Furthermore, 1 exclusion criterion to undergo MR imaging examination in the Generation R Study design is a history of moderate-to-severe head injuries with loss of consciousness. In previous literature, a possible relationship between an enlarged CSP and traumatic brain injury has been reported in adults as well as in children.39,40 Therefore, exclusion of children with previous moderate-to-severe brain injury potentially resulted in selection bias. In addition, missing values on internalizing and externalizing symptoms, nonverbal IQ, and certain covariates are a potential limitation of the study design, but we applied multiple imputation methods to reduce the potential bias introduced as a result of missing data to a minimum.

The strengths of the current study are the standardized MR imaging measurements obtained in a large population-based sample of 1070 children of different ethnicities and backgrounds. The study contains an extensive data collection with a broad range of physiologic and environmental measures. Therefore, it includes valuable data representative of the pediatric population in general.

Conclusions

The CSP is a structural brain variation without cognitive or behavioral implications in this population-based sample of school-aged children. However, we did find a relationship between CSP and global and regional volumetric brain measures, but the clinical relevance of this relationship is as yet uncertain.

Footnotes

  • Marjolein H.G. Dremmen and Roos H. Bouhuis contributed equally to this work.

  • Disclosures: Marjolein H.G. Dremmen—RELATED: Grant: the Netherlands Organization for Health Research and Development*; UNRELATED: Employment: Pediatric Radiologist at Erasmus Medical Center, Rotterdam. Roos H. Bouhuis—RELATED: Grant: the Netherlands Organization for Health Research and Development.* Hanan El Marroun—RELATED: Grant: European Union, Comments: The Horizon 2020 research and innovation program (grant agreement No.633595 DynaHEALTH and No.733206 LifeCycle) of the European Union.* Frank C. Verhulst—UNRELATED: Royalties: distributor of the Dutch translations of the Achenbach System of Empirically Based Assessment, from which I receive remuneration. Tonya White—RELATED: Grant: the Netherlands Organization for Health Research and Development.* *Money paid to the institution.

  • This study was financially supported through Netherlands Organization for Health Research and Development TOP project No. 91211021. The general design of the Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam; the Erasmus University Rotterdam; the Netherlands Organization for Health Research and Development; and the Netherlands Organization for Scientific Research, the Ministry of Health, Welfare and Sport.

Indicates open access to non-subscribers at www.ajnr.org

REFERENCES

  1. 1.↵
    1. Sarwar M
    . The septum pellucidum: normal and abnormal. AJNR Am J Neuroradiol 1989;10:989–1005 pmid:2505543
    Abstract/FREE Full Text
  2. 2.↵
    1. Dickey CC,
    2. McCarley RW,
    3. Xu ML, et al
    . MRI abnormalities of the hippocampus and cavum septi pellucidi in females with schizotypal personality disorder. Schizophr Res 2007;89:49–58 doi:10.1016/j.schres.2006.08.004 pmid:17027236
    CrossRefPubMed
  3. 3.↵
    1. Choi JS,
    2. Kang DH,
    3. Park JY, et al
    . Cavum septum pellucidum in subjects at ultra-high risk for psychosis: compared with first-degree relatives of patients with schizophrenia and healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1326–30 doi:10.1016/j.pnpbp.2008.04.011 pmid:18513845
    CrossRefPubMed
  4. 4.↵
    1. Shunk H
    . Congenital dilatations of the septi pellucidum. Radiology 1963;81:610–18 doi:10.1148/81.4.610 pmid:14078558
    CrossRefPubMed
  5. 5.↵
    1. Nopoulos PC,
    2. Giedd JN,
    3. Andreasen NC, et al
    . Frequency and severity of enlarged cavum septi pellucidi in childhood-onset schizophrenia. Am J Psychiatry 1998;155:1074–79 doi:10.1176/ajp.155.8.1074 pmid:9699696
    CrossRefPubMed
  6. 6.↵
    1. Hagino H,
    2. Suzuki M,
    3. Kurokawa K, et al
    . Magnetic resonance imaging study of the cavum septi pellucidi in patients with schizophrenia. Am J Psychiatry 2001;158:1717–19 doi:10.1176/appi.ajp.158.10.1717 pmid:11579008
    CrossRefPubMed
  7. 7.↵
    1. Rajarethinam R,
    2. Miedler J,
    3. DeQuardo J, et al
    . Prevalence of cavum septum pellucidum in schizophrenia studied with MRI. Schizophr Res 2001;48:201–05 doi:10.1016/S0920-9964(00)00110-9 pmid:11295373
    CrossRefPubMed
  8. 8.↵
    1. Crippa JA,
    2. Uchida R,
    3. Busatto GF, et al
    . The size and prevalence of the cavum septum pellucidum are normal in subjects with panic disorder. Braz J Med Biol Res 2004;37:371–74 doi:10.1590/S0100-879X2004000300013 pmid:15060705
    CrossRefPubMed
  9. 9.↵
    1. de Souza Crippa JA,
    2. Zuardi AW,
    3. Busatto GF, et al
    . Cavum septum pellucidum and adhesio interthalamica in schizophrenia: an MRI study. Eur Psychiatry 2006;21:291–99 doi:10.1016/j.eurpsy.2005.09.010 pmid:16406503
    CrossRefPubMed
  10. 10.↵
    1. Flashman LA,
    2. Roth RM,
    3. Pixley HS, et al
    . Cavum septum pellucidum in schizophrenia: clinical and neuropsychological correlates. Psychiatry Res 2007;154:147–55 doi:10.1016/j.pscychresns.2006.09.001 pmid:17291728
    CrossRefPubMed
  11. 11.↵
    1. Kim MJ,
    2. Lyoo IK,
    3. Dager SR, et al
    . The occurrence of cavum septi pellucidi enlargement is increased in bipolar disorder patients. Bipolar Disord 2007;9:274–80 doi:10.1111/j.1399-5618.2007.00442.x pmid:17430302
    CrossRefPubMed
  12. 12.↵
    1. Takahashi T,
    2. Suzuki M,
    3. Hagino H, et al
    . Prevalence of large cavum septi pellucidi and its relation to the medial temporal lobe structures in schizophrenia spectrum. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1235–41 doi:10.1016/j.pnpbp.2007.04.019 pmid:17553605
    CrossRefPubMed
  13. 13.↵
    1. Takahashi T,
    2. Yücel M,
    3. Lorenzetti V, et al
    . Midline brain structures in patients with current and remitted major depression. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:1058–63 doi:10.1016/j.pnpbp.2009.05.020 pmid:19505522
    CrossRefPubMed
  14. 14.↵
    1. Chon MW,
    2. Choi JS,
    3. Kang DH, et al
    . MRI study of the cavum septum pellucidum in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 2010;260:337–43 doi:10.1007/s00406-009-0081-6 pmid:19856198
    CrossRefPubMed
  15. 15.↵
    1. Raine A,
    2. Lee L,
    3. Yang Y, et al
    . Neurodevelopmental marker for limbic maldevelopment in antisocial personality disorder and psychopathy. Br J Psychiatry 2010;197:186–92 doi:10.1192/bjp.bp.110.078485 pmid:20807962
    Abstract/FREE Full Text
  16. 16.↵
    1. Hwang J,
    2. Kim JE,
    3. Kaufman MJ, et al
    . Enlarged cavum septum pellucidum as a neurodevelopmental marker in adolescent-onset opiate dependence. PLoS One 2013;8:e78590 doi:10.1371/journal.pone.0078590 pmid:24205275
    CrossRefPubMed
  17. 17.↵
    1. Galarza M,
    2. Merlo AB,
    3. Ingratta A, et al
    . Cavum septum pellucidum and its increased prevalence in schizophrenia: a neuroembryological classification. J Neuropsychiatry Clin Neurosci 2004;16:41–46 doi:10.1176/jnp.16.1.41 pmid:14990758
    CrossRefPubMed
  18. 18.↵
    1. Kasai K,
    2. McCarley RW,
    3. Salisbury DF, et al
    . Cavum septi pellucidi in first-episode schizophrenia and first-episode affective psychosis: an MRI study. Schizophr Res 2004;71:65–76 doi:10.1016/j.schres.2003.12.010 pmid:15374574
    CrossRefPubMed
  19. 19.↵
    1. White SF,
    2. Brislin S,
    3. Sinclair S, et al
    . The relationship between large cavum septum pellucidum and antisocial behavior, callous-unemotional traits and psychopathy in adolescents. J Child Psychol Psychiatry 2013;54:575–81 doi:10.1111/j.1469-7610.2012.02603.x pmid:22934662
    CrossRefPubMed
  20. 20.↵
    1. Rajarethinam R,
    2. Sohi J,
    3. Arfken C, et al
    . No difference in the prevalence of cavum septum pellucidum (CSP) between first-episode schizophrenia patients, offspring of schizophrenia patients and healthy controls. Schizophr Res 2008;103:22–25 doi:10.1016/j.schres.2007.11.031 pmid:18248791
    CrossRefPubMed
  21. 21.↵
    1. Takahashi T,
    2. Malhi GS,
    3. Wood SJ, et al
    . Midline brain abnormalities in established bipolar affective disorder. J Affect Disord 2010;122:301–05 doi:10.1016/j.jad.2009.09.003 pmid:19782407
    CrossRefPubMed
  22. 22.↵
    1. Nopoulos P,
    2. Berg S,
    3. Castellenos FX, et al
    . Developmental brain anomalies in children with attention-deficit hyperactivity disorder. J Child Neurol 2000;15:102–08 doi:10.1177/088307380001500208 pmid:10695895
    CrossRefPubMed
  23. 23.↵
    1. Nopoulos P,
    2. Krie A,
    3. Andreasen NC
    . Enlarged cavum septi pellucidi in patients with schizophrenia: clinical and cognitive correlates. J Neuropsychiatry Clin Neurosci 2000;12:344–49 doi:10.1176/jnp.12.3.344 pmid:10956567
    CrossRefPubMed
  24. 24.↵
    1. Bodensteiner JB,
    2. Schaefer GB,
    3. Craft JM
    . Cavum septi pellucidi and cavum vergae in normal and developmentally delayed populations. J Child Neurol 1998;13:120–21 doi:10.1177/088307389801300305 pmid:9535237
    CrossRefPubMed
  25. 25.↵
    1. Swayze VW 2nd.,
    2. Johnson VP,
    3. Hansen JW, et al
    . Magnetic resonance imaging of brain anomalies in fetal alcohol syndrome. Pediatrics 1997;99:232–40 doi:10.1542/peds.99.2.232 pmid:9024452
    Abstract/FREE Full Text
  26. 26.↵
    1. Renier D,
    2. Arnaud E,
    3. Cinalli G, et al
    . Prognosis for mental function in Apert's syndrome. J Neurosurg 1996;85:66–72 pmid:8683284
    CrossRefPubMed
  27. 27.↵
    1. Jaddoe VW,
    2. Mackenbach JP,
    3. Moll HA, et al
    . The Generation R Study: design and cohort profile. Eur J Epidemiol 2006;21:475–84 doi:10.1007/s10654-006-9022-0 pmid:16826450
    CrossRefPubMed
  28. 28.↵
    1. White T,
    2. El Marroun H,
    3. Nijs I, et al
    . Pediatric population-based neuroimaging and the Generation R Study: the intersection of developmental neuroscience and epidemiology. Eur J Epidemiol. 2013;28:99–111 doi:10.1007/s10654-013-9768-0 pmid:23354984
    CrossRefPubMed
  29. 29.↵
    1. White T,
    2. Muetzel RL,
    3. El Marroun H, et al
    . Paediatric population neuroimaging and the Generation R Study: the second wave. Eur J Epidemiol 2018;33:99–125 doi:10.1007/s10654-017-0319-y pmid:29064008
    CrossRefPubMed
  30. 30.↵
    1. Muetzel RL,
    2. Blanken LME,
    3. Thijssen S, et al
    . Variability in ICA-derived resting-state networks in 6-to-10 year-old children. Hum Brain Mapp 2016;37:4286–4300 doi:10.1002/hbm.23309 pmid:27417416
    CrossRefPubMed
  31. 31.↵
    1. White T,
    2. Jansen PR,
    3. Muetzel RL, et al
    . Automated quality assessment of structural magnetic resonance images in children: comparison with visual inspection and surface-based reconstruction. Hum Brain Mapp 2018;39:1218–31 doi:10.1002/hbm.23911 pmid:29206318
    CrossRefPubMed
  32. 32.↵
    1. Fischl B,
    2. Salat DH,
    3. Busa E, et al
    . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341–55 doi:10.1016/S0896-6273(02)00569-X pmid:11832223
    CrossRefPubMed
  33. 33.↵
    1. Achenbach TM,
    2. Rescorla LA
    . Manual for the ASEBA Preschool Forms and Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, & Families; 2000
  34. 34.↵
    1. Basten M,
    2. van der Ende J,
    3. Tiemeier H, et al
    . Nonverbal intelligence in young children with dysregulation: the Generation R Study. Eur Child Adolesc Psychiatry 2014;23:1061–70 doi:10.1007/s00787-014-0551-x pmid:24802760
    CrossRefPubMed
  35. 35.↵
    1. Moore C,
    2. O'Keefe S,
    3. Lawhorn D, et al., et al
    . Concurrent validity of the Snijders-Oomen Nonverbal Intelligence Test 2 1/2–7–Revised with the Wechsler Preschool and Primary Scale of Intelligence–Revised. Psychological Reports 1998;82:619–25 doi:10.2466/pr0.1998.82.2.619
    CrossRef
  36. 36.↵
    1. Snijders JH,
    2. Snijders-Oomen AW,
    3. Tellegen PJ, et al
    . SON-R 21/2–7: Snijders-Oomen Niet-Verbale Intelligentietest—Handleiding en Verantwoording. Amsterdam: Boom Testuitgevers; 2005
  37. 37.↵
    1. Galwey NW
    . A new measure of the effective number of tests, a practical tool for comparing families of non-independent significance tests. Genet Epidemiol 2009;33:559–68 doi:10.1002/gepi.20408 pmid:19217024
    CrossRefPubMed
  38. 38.↵
    1. Holland D,
    2. Chang L,
    3. Ernst TM, et al
    . Structural growth trajectories and rates of change in the first 3 months of infant brain development. JAMA Neurol 2014;71:1266–74 doi:10.1001/jamaneurol.2014.1638 pmid:25111045
    CrossRefPubMed
  39. 39.↵
    1. Lee JK,
    2. Wu J,
    3. Banks S, et al
    . Prevalence of traumatic findings on routine MRI in a large cohort of professional fighters. AJNR Am J Neuroradiol 2017;38:1303–10 doi:10.3174/ajnr.A5175 pmid:28473342
    Abstract/FREE Full Text
  40. 40.↵
    1. Silk T,
    2. Beare R,
    3. Crossley L, et al
    . Cavum septum pellucidum in pediatric traumatic brain injury. Psychiatry Res 2013;213:186–92 doi:10.1016/j.pscychresns.2013.03.001 pmid:23816190
    CrossRefPubMed
  41. 41.
    1. El Marroun H,
    2. White TJ,
    3. van der Knaap NJ, et al
    . Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children. Br J Psychiatry 2014;205:95–102 doi:10.1192/bjp.bp.113.127746 pmid:25252317
    Abstract/FREE Full Text
  • Received August 29, 2018.
  • Accepted after revision December 1, 2018.
  • © 2019 by American Journal of Neuroradiology
View Abstract
PreviousNext
Back to top
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cavum Septum Pellucidum in the General Pediatric Population and Its Relation to Surrounding Brain Structure Volumes, Cognitive Function, and Emotional or Behavioral Problems
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
M.H.G. Dremmen, R.H. Bouhuis, L.M.E. Blanken, R.L. Muetzel, M.W. Vernooij, H.E. Marroun, V.W.V. Jaddoe, F.C. Verhulst, H. Tiemeier, T. White
Cavum Septum Pellucidum in the General Pediatric Population and Its Relation to Surrounding Brain Structure Volumes, Cognitive Function, and Emotional or Behavioral Problems
American Journal of Neuroradiology Jan 2019, DOI: 10.3174/ajnr.A5939

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Cavum Septum Pellucidum in the General Pediatric Population and Its Relation to Surrounding Brain Structure Volumes, Cognitive Function, and Emotional or Behavioral Problems
M.H.G. Dremmen, R.H. Bouhuis, L.M.E. Blanken, R.L. Muetzel, M.W. Vernooij, H.E. Marroun, V.W.V. Jaddoe, F.C. Verhulst, H. Tiemeier, T. White
American Journal of Neuroradiology Jan 2019, DOI: 10.3174/ajnr.A5939
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Subcortical Segmentation of the Fetal Brain in 3D Ultrasound using Deep Learning
  • Neuroanatomical Risk Factors for Post Traumatic Stress Disorder (PTSD) in Recent Trauma Survivors
  • Crossref (13)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Subcortical segmentation of the fetal brain in 3D ultrasound using deep learning
    Linde S. Hesse, Moska Aliasi, Felipe Moser, Monique C. Haak, Weidi Xie, Mark Jenkinson, Ana I.L. Namburete
    NeuroImage 2022 254
  • NANS-CDG: Delineation of the Genetic, Biochemical, and Clinical Spectrum
    Bibiche den Hollander, Anne Rasing, Merel A. Post, Willemijn M. Klein, Machteld M. Oud, Marion M. Brands, Lonneke de Boer, Udo F. H. Engelke, Peter van Essen, Sabine A. Fuchs, Charlotte A. Haaxma, Brynjar O. Jensson, Leo A. J. Kluijtmans, Anna Lengyel, Klaske D. Lichtenbelt, Elsebet Østergaard, Gera Peters, Ramona Salvarinova, Marleen E. H. Simon, Kari Stefansson, Ólafur Thorarensen, Ulrike Ulmen, Karlien L. M. Coene, Michèl A. Willemsen, Dirk J. Lefeber, Clara D. M. van Karnebeek
    Frontiers in Neurology 2021 12
  • The Neurological Consequences of Engaging in Australian Collision Sports
    Georgia F. Symons, Meaghan Clough, Joanne Fielding, William T. O'Brien, Claire E. Shepherd, David K. Wright, Sandy R. Shultz
    Journal of Neurotrauma 2020 37 5
  • Examining for Cavum Septum Pellucidum and Ventricular Enlargement in Retired Elite-Level Rugby League Players
    Peter Stanwell, Grant L. Iverson, Ryan Van Patten, Rudolph J. Castellani, Paul McCrory, Andrew J. Gardner
    Frontiers in Neurology 2022 13
  • Neuroanatomical Risk Factors for Posttraumatic Stress Disorder in Recent Trauma Survivors
    Ziv Ben-Zion, Moran Artzi, Dana Niry, Nimrod Jackob Keynan, Yoav Zeevi, Roee Admon, Haggai Sharon, Pinchas Halpern, Israel Liberzon, Arieh Y. Shalev, Talma Hendler
    Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2020 5 3
  • In-depth characterization of neuroradiological findings in a large sample of individuals with autism spectrum disorder and controls
    Sara Ambrosino, Hasnaa Elbendary, Maarten Lequin, Dominique Rijkelijkhuizen, Tobias Banaschewski, Simon Baron-Cohen, Nico Bast, Sarah Baumeister, Jan Buitelaar, Tony Charman, Daisy Crawley, Flavio Dell'Acqua, Hannah Hayward, Rosemary Holt, Carolin Moessnang, Antonio M. Persico, Roberto Sacco, Antonia San José Cáceres, Julian Tillmann, Eva Loth, Christine Ecker, Bob Oranje, Declan Murphy, Sarah Durston
    NeuroImage: Clinical 2022 35
  • Enlarged cavum septum pellucidum as a neuroimaging signature of head impact exposure
    Suzie Kamps, Hugo L Hempel, Suzan van Amerongen, Hannah de Bruin, Fleur H C van der Linden, Vikram Venkatraghavan, Wiesje M van der Flier, Yolande A L Pijnenburg, Frederik Barkhof, Philip Scheltens, Rik Ossenkoppele, Everard G B Vijverberg
    Brain Communications 2025 7 2
  • Clinical phenotype and genetic characteristics of SZT2 related diseases: A case report and literature review
    Xin Zhang, Yuzeng Han, Li Yang, Na Xu, Liping Zhu, Shiyan Qiu, Yufen Li, Liyun Xu, Xixi Yu
    Seizure: European Journal of Epilepsy 2024 114
  • Investigation of septum pellucidum and its variations with magnetic resonance imaging
    Keziban KARACAN, Alper KARACAN
    Journal of Surgery and Medicine 2021 5 9
  • Midline brain structures in adult Niemann-Pick type C disease: a cross-sectional study
    Mark Walterfang, Tsutomu Takahashi, Maria A. Di Biase, Vanessa L. Cropley, Daiki Sasabayashi, Michio Suzuki, Dennis Velakoulis, Christos Pantelis
    Acta Neuropsychiatrica 2024 36 6

More in this TOC Section

  • FRACTURE MR in Congenital Vertebral Anomalies
  • Neuroimaging Delineation and Progression of SLSMD
  • fetal brain development of 10 weeks gestation
Show more PEDIATRIC NEUROIMAGING

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire